Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 1
1972 2
1979 1
1981 1
1982 1
1986 3
1987 2
1988 2
1989 8
1990 7
1991 3
1992 5
1993 3
1994 4
1995 8
1996 5
1997 10
1998 16
1999 16
2000 11
2001 6
2002 20
2003 13
2004 12
2005 8
2006 15
2007 13
2008 28
2009 31
2010 36
2011 24
2012 33
2013 37
2014 29
2015 15
2016 18
2017 28
2018 38
2019 46
2020 62
2021 66
2022 88
2023 65
2024 60
2025 42

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

820 results

Results by year

Filters applied: . Clear all
Page 1
Response.
Shichijo S, Takeuchi Y, Shimokawa T. Shichijo S, et al. Among authors: shimokawa t. Gastrointest Endosc. 2022 Mar;95(3):593-595. doi: 10.1016/j.gie.2021.11.024. Gastrointest Endosc. 2022. PMID: 35180943 No abstract available.
JCS/JACR 2021 Guideline on Rehabilitation in Patients With Cardiovascular Disease.
Makita S, Yasu T, Akashi YJ, Adachi H, Izawa H, Ishihara S, Iso Y, Ohuchi H, Omiya K, Ohya Y, Okita K, Kimura Y, Koike A, Kohzuki M, Koba S, Sata M, Shimada K, Shimokawa T, Shiraishi H, Sumitomo N, Takahashi T, Takura T, Tsutsui H, Nagayama M, Hasegawa E, Fukumoto Y, Furukawa Y, Miura SI, Yasuda S, Yamada S, Yamada Y, Yumino D, Yoshida T, Adachi T, Ikegame T, Izawa KP, Ishida T, Ozasa N, Osada N, Obata H, Kakutani N, Kasahara Y, Kato M, Kamiya K, Kinugawa S, Kono Y, Kobayashi Y, Koyama T, Sase K, Sato S, Shibata T, Suzuki N, Tamaki D, Yamaoka-Tojo M, Nakanishi M, Nakane E, Nishizaki M, Higo T, Fujimi K, Honda T, Matsumoto Y, Matsumoto N, Miyawaki I, Murata M, Yagi S, Yanase M, Yamada M, Yokoyama M, Watanabe N, Itoh H, Kimura T, Kyo S, Goto Y, Nohara R, Hirata KI; Japanese Circulation Society/the Japanese Association of Cardiac Rehabilitation Joint Working Group. Makita S, et al. Among authors: shimokawa t. Circ J. 2022 Dec 23;87(1):155-235. doi: 10.1253/circj.CJ-22-0234. Epub 2022 Dec 9. Circ J. 2022. PMID: 36503954 Free article. No abstract available.
Editorial: New frontiers in radiobiology.
Ebner DK, Shimokawa T, Tinganelli W, Vandevoorde C. Ebner DK, et al. Among authors: shimokawa t. Front Public Health. 2023 Mar 27;11:1181656. doi: 10.3389/fpubh.2023.1181656. eCollection 2023. Front Public Health. 2023. PMID: 37050959 Free PMC article. No abstract available.
Durvalumab with etoposide and carboplatin for patients with extensive-stage small cell lung cancer and interstitial lung disease: A multicenter, open-label prospective trial.
Shibaki R, Fujimoto D, Miyauchi E, Tsukita Y, Nakachi I, Arai D, Sakata Y, Shingu N, Shimokawa T, Kijima T, Tamiya M, Kawana S, Hara S, Saito G, Sato Y, Yokoyama T, Sakata S, Taniguchi Y, Hata A, Matsumoto H, Yamaguchi T, Yamamoto N. Shibaki R, et al. Among authors: shimokawa t. Lung Cancer. 2024 Oct;196:107958. doi: 10.1016/j.lungcan.2024.107958. Epub 2024 Sep 19. Lung Cancer. 2024. PMID: 39312871 Clinical Trial.
Randomized Phase III Trial of Ramucirumab Beyond Progression Plus Irinotecan in Patients With Ramucirumab-Refractory Advanced Gastric Cancer: RINDBeRG Trial.
Sakai D, Kadowaki S, Kawabata R, Hara H, Satake H, Takahashi M, Takeno A, Imai H, Minashi K, Kawakami T, Boku S, Matsuyama J, Sakamoto Y, Sawada K, Kataoka M, Kawakami H, Shimokawa T, Boku N, Satoh T. Sakai D, et al. Among authors: shimokawa t. J Clin Oncol. 2025 Jul;43(19):2196-2207. doi: 10.1200/JCO.24.01119. Epub 2025 May 23. J Clin Oncol. 2025. PMID: 40408613 Free PMC article. Clinical Trial.
Particle Beam Radiobiology Status and Challenges: A PTCOG Radiobiology Subcommittee Report.
Ahmad R, Barcellini A, Baumann K, Benje M, Bender T, Bragado P, Charalampopoulou A, Chowdhury R, Davis AJ, Ebner DK, Eley J, Kloeber JA, Mutter RW, Friedrich T, Gutierrez-Uzquiza A, Helm A, Ibáñez-Moragues M, Iturri L, Jansen J, Morcillo MÁ, Puerta D, Kokko AP, Sánchez-Parcerisa D, Scifoni E, Shimokawa T, Sokol O, Story MD, Thariat J, Tinganelli W, Tommasino F, Vandevoorde C, von Neubeck C. Ahmad R, et al. Among authors: shimokawa t. Int J Part Ther. 2024 Aug 8;13:100626. doi: 10.1016/j.ijpt.2024.100626. eCollection 2024 Sep. Int J Part Ther. 2024. PMID: 39258166 Free PMC article. Review.
Topical sirolimus therapy for cutaneous vascular anomalies: A randomized phase II clinical trial.
Jinnin M, Shimokawa T, Kishi A, Hayashi N, Nagahama M, Kubo A, Ozeki M, Shimada S, Fukushima S, Kawabata T, Okuyama T, Okubo A, Sawai Y, Hayashi A, Kurimoto-Nishiguchi M, Sakata M, Kunimoto K, Yamamoto Y. Jinnin M, et al. Among authors: shimokawa t. J Dermatol. 2025 May;52(5):872-887. doi: 10.1111/1346-8138.17688. Epub 2025 Mar 5. J Dermatol. 2025. PMID: 40040594 Clinical Trial.
SHIP2 and its involvement in various diseases.
Suwa A, Kurama T, Shimokawa T. Suwa A, et al. Among authors: shimokawa t. Expert Opin Ther Targets. 2010 Jul;14(7):727-37. doi: 10.1517/14728222.2010.492780. Expert Opin Ther Targets. 2010. PMID: 20536411 Review.
820 results